Product Information
IBUPROFEN-FAMOTIDIN 800-26.6 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.7693 per EA under NDC 31722031590. Its NADAC has been published 150 times since Oct 11, 2023.
FDA first approved this application on Mar 15, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
26.6; 800 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722031590
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FAMOTIDINE; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA216814FDA Approved
3/15/2023
TE Code
AB
On Market Since
3/15/2023
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 75.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7693 per EA |
|---|---|
| All-time high | $3.1024 (Dec 13, 2023) |
| All-time low | $0.6418 (Feb 18, 2026) |
| 52-week high | $1.0176 |
| 52-week low | $0.6418 |
| Median price | $1.0001 |
| Average price | $1.3237 |
| Largest weekly change | -44.8% (Mar 20, 2024) |
| Weeks tracked | 150 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN-FAMOTIDIN 800-26.6 MG?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN-FAMOTIDIN 800-26.6 MG, manufactured by Camber Pharmaceuticals Inc., is $0.7693 per EA (NDC 31722031590), effective Aug 19, 2026.
How has the price of IBUPROFEN-FAMOTIDIN 800-26.6 MG changed over time?
Over the history we have for it, the NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has declined 75.2%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for IBUPROFEN-FAMOTIDIN 800-26.6 MG?
Since Oct 11, 2023, the NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has ranged from a low of $0.6418 (Feb 18, 2026) to a high of $3.1024 (Dec 13, 2023), with a median of $1.0001 per EA.
Are there cheaper alternatives to IBUPROFEN-FAMOTIDIN 800-26.6 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN-FAMOTIDIN 800-26.6 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures IBUPROFEN-FAMOTIDIN 800-26.6 MG?
IBUPROFEN-FAMOTIDIN 800-26.6 MG (NDC 31722031590) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.